Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
NANOSONICS LIMITED (NAN)ASX AI Signals has generated 2 signal(s) for NAN during the last 90 days, indicating Moderate trading activity
Latest NAN Signals | |
| 26/05/2026 | SELL |
| 29/04/2026 | SELL |
NAN Share Price | |
| Current Price | $3.350 |
| 52 Week High | $4.730 |
| 52 Week Low: | $3.090 |
| Trading at (% of 52 Week High) | 70.82% |
Nanosonics Limited (ASX: NAN) is a medical technology company that develops and commercializes infection prevention solutions. Its flagship product, Trophon®, is a disinfection system designed for use with ultrasound probes to reduce the risk of healthcare-associated infections. The company operates globally, supplying hospitals and clinics with its innovative healthcare products.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for NANOSONICS LIMITED is supported by moderate bearish signals, but the confidence is tempered by potential volatility and sector-specific factors that could influence price movements.
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But the last three years have been particularly tough on longer term Nanosonics Limited (ASX:NAN) shareholders. So they might be feeling emotional about the 56% share price collapse, in Key Insights
Given the large stake in the stock by institutions, Nanosonics' stock price might be vulnerable to their trading decisions A total of 10 investors have a majority stake in the company with 53% ownership Insiders own 15% of Nanosonics
A look at the shareholders of Nanosonics Limited (A Key Insights
Nanosonics' estimated fair value is AU$4.80 based on 2 Stage Free Cash Flow to Equity With AU$4.39 share price, Nanosonics appears to be trading close to its estimated fair value Analyst price target for NAN is AU$4.56 which is 5.0% below our fair value estimate
In this article we are While Nanosonics Limited (ASX:NAN) might not be the most widely known stock at the moment, it saw a double-digit share price rise of over 10% in the past couple of months on the ASX. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already pr It is hard to get excited after looking at Nanosonics' (ASX:NAN) recent performance, when its stock has declined 17% over the past three months. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. Specifically, we decidedLatest NANOSONICS LIMITED(NAN) News
The three-year underlying earnings growth at Nanosonics (ASX:NAN) is promising, but the shareholders are still in the red over that time
Nanosonics Limited (ASX:NAN) is largely controlled by institutional shareholders who own 63% of the company
A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Is Now An Opportune Moment To Examine Nanosonics Limited (ASX:NAN)?
Should Weakness in Nanosonics Limited's (ASX:NAN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial